Congress · 117th Congress
Lobbyists, advocates seek to revise budget bill’s drug price changes
Under the House bill, the Department of Health and Human Services would negotiate prices for insulin and up to 10 drugs without generic competition in 2025, 15 drugs in 2026 and 2027, and 20 drugs afterward